Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10035966HBVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS30067436HIVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061554HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061565HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061861HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS44008599HTLV-1ENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS44039492HTLV-1ENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TCGA Plot Options
Drug Information
GeneABCB1
DrugBank IDDB14069
Drug NameONT-093
Target IDBE0001032
UniProt IDP08183
Regulation Typeinhibitor
PubMed IDs16012790; 10850444; 20216335
CitationsChi KN, Chia SK, Dixon R, Newman MJ, Wacher VJ, Sikic B, Gelmon KA: A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer. Invest New Drugs. 2005 Aug;23(4):311-5. doi: 10.1007/s10637-005-1439-x.@@Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES, Mayer LD: Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Res. 2000 Jun 1;60(11):2964-72.@@Hodges LM, Markova SM, Chinn LW, Gow JM, Kroetz DL, Klein TE, Altman RB: Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmacogenet Genomics. 2011 Mar;21(3):152-61. doi: 10.1097/FPC.0b013e3283385a1c.
GroupsInvestigational
Direct Classification
SMILES[H]C(COCC)=C([H])C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=C(NC(C)C)C=C1)C1=CC=C(NC(C)C)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL313113